Variation between Point-of-care and Laboratory HbA1c testing in Clinical Practice.
CONCLUSION: Point-of-care HbA1c testing should not be used in solidarity to diagnosis pre-diabetes and diabetes. When using HbA1c results to guide therapy, self-monitoring of blood glucose and symptoms of both hypo- and hyperglycemia should be correlated to help determine appropriate therapy.
PMID: 31536634 [PubMed - in process]
Source: Puerto Rico Health Sciences Journal - Category: International Medicine & Public Health Tags: P R Health Sci J Source Type: research
More News: Diabetes | Endocrinology | International Medicine & Public Health | Laboratory Medicine | Study